X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs CADILA HEALTHCARE - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS CADILA HEALTHCARE J.B.CHEMICALS/
CADILA HEALTHCARE
 
P/E (TTM) x 15.7 32.4 48.4% View Chart
P/BV x 2.5 6.4 38.7% View Chart
Dividend Yield % 0.2 0.7 21.3%  

Financials

 J.B.CHEMICALS   CADILA HEALTHCARE
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
CADILA HEALTHCARE
Mar-17
J.B.CHEMICALS/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs318460 69.2%   
Low Rs200305 65.4%   
Sales per share (Unadj.) Rs148.092.1 160.7%  
Earnings per share (Unadj.) Rs19.114.8 128.8%  
Cash flow per share (Unadj.) Rs23.918.5 129.6%  
Dividends per share (Unadj.) Rs0.503.20 15.6%  
Dividend yield (eoy) %0.20.8 23.1%  
Book value per share (Unadj.) Rs128.968.0 189.7%  
Shares outstanding (eoy) m84.821,023.74 8.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.74.2 42.1%   
Avg P/E ratio x13.625.8 52.5%  
P/CF ratio (eoy) x10.820.7 52.2%  
Price / Book Value ratio x2.05.6 35.7%  
Dividend payout %2.621.6 12.1%   
Avg Mkt Cap Rs m21,951391,581 5.6%   
No. of employees `0002.716.9 16.2%   
Total wages/salary Rs m1,84115,002 12.3%   
Avg. sales/employee Rs Th4,590.95,594.5 82.1%   
Avg. wages/employee Rs Th673.4890.1 75.7%   
Avg. net profit/employee Rs Th592.1899.9 65.8%   
INCOME DATA
Net Sales Rs m12,55194,295 13.3%  
Other income Rs m5421,286 42.1%   
Total revenues Rs m13,09395,581 13.7%   
Gross profit Rs m2,05519,036 10.8%  
Depreciation Rs m4123,750 11.0%   
Interest Rs m96450 21.3%   
Profit before tax Rs m2,08816,122 13.0%   
Minority Interest Rs m0338 -0.1%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3 0.0%   
Tax Rs m4691,289 36.4%   
Profit after tax Rs m1,61915,168 10.7%  
Gross profit margin %16.420.2 81.1%  
Effective tax rate %22.58.0 281.0%   
Net profit margin %12.916.1 80.2%  
BALANCE SHEET DATA
Current assets Rs m7,77860,223 12.9%   
Current liabilities Rs m4,35853,058 8.2%   
Net working cap to sales %27.27.6 358.6%  
Current ratio x1.81.1 157.2%  
Inventory Days Days5570 78.3%  
Debtors Days Days8088 90.8%  
Net fixed assets Rs m5,71372,984 7.8%   
Share capital Rs m1701,024 16.6%   
"Free" reserves Rs m10,54768,576 15.4%   
Net worth Rs m10,93769,600 15.7%   
Long term debt Rs m024,684 0.0%   
Total assets Rs m15,574152,207 10.2%  
Interest coverage x22.836.8 62.0%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.6 130.1%   
Return on assets %11.010.3 107.3%  
Return on equity %14.821.8 67.9%  
Return on capital %20.017.9 111.3%  
Exports to sales %48.70-   
Imports to sales %7.10-   
Exports (fob) Rs m6,115NA-   
Imports (cif) Rs m889NA-   
Fx inflow Rs m6,16921,280 29.0%   
Fx outflow Rs m1,28510,874 11.8%   
Net fx Rs m4,88410,406 46.9%   
CASH FLOW
From Operations Rs m1,39713,495 10.3%  
From Investments Rs m-320-29,103 1.1%  
From Financial Activity Rs m-1,19623,158 -5.2%  
Net Cashflow Rs m-1027,556 -1.4%  

Share Holding

Indian Promoters % 55.4 74.8 74.1%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 8.3 40.8%  
FIIs % 3.9 5.9 66.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 11.0 336.4%  
Shareholders   30,437 44,069 69.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   FULFORD INDIA  VENUS REMEDIES  STERLING BIOTECH  ELDER PHARMA  AUROBINDO PHARMA  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Sensex Touching Record Highs, Rally in Banking Stocks and Key Stocks in Action Today(Pre-Open)

BSE Sensex is on a roll. The index touched a record high of 35,000 on Wednesday and further inched upwards to end yesterday's trade at a level of 35,260.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jan 18, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS